FOSTER CITY, Calif.--(BUSINESS WIRE)--Entelos, Inc. (LSE:ENTL), a leading life sciences company building predictive computer models of human physiology and “virtual patients” for drug discovery and development, today is updating the market ahead of its pre-close period for the six-month period ended 30 June 2007.
